Clinical Trial Laboratory Services

Comprehensive laboratory support for all phases of clinical trial testing.

Contact Us

Trending Topics


The Modulatory Effects of a PI3Kδ Specific Small Molecule Inhibitor (IOA-244) on Basophil Degranulation Measured by Flow Cytometry

During this short 8-minute presentation, our staff scientist Eirini Kamileri, PhD evaluates the performance of the IOA-244 drug (a selective PI3Kδ inhibitor), on IgE-induced basophilic activation, through flow cytometry.


Validation of CLL ERIC MRD Flow Cytometry Panel in a CAP/CLIA-Compliant Model

During this short 11-minute video, our staff scientist Marc Campillos, PhD discusses validation for the CLL ERIC MRD flow cytometry assay in a CAP/CLIA-compliant model to confirm performance of the assay in terms of precision, sensitivity and stability, while including run pass fail criteria using QC reagents.


Supporting CAR T-Cell Development with a Translational Biomarker Strategy

Biomarkers play a critical part in accelerating CAR T-cell development. This 25-minute session, delves into the importance of a translational biomarker strategy in assessing safety and efficacy to navigate regulatory pathways in rapid development of CAR T-cell therapies.


De-Risk and Streamline Your Drug Substance & Drug Product Testing

The development of a new biologic requires effective management of time and risk. The drug manufacturing process will progress in scale and likely location for both drug substance and drug product.


Challenges & Best Practices in Supporting Clinical Bioanalysis in China

In this on-demand webinar, learn more about the key considerations and best practices for supporting your global clinical trial with regulated bioanalysis in China. Topics covered include: special requirements for China submission studies, differences in global quality standards and technical expertise, resourcing and customs challenges in China, and advanced technologies for supporting existing and emerging modalities.

Info Sheet

Testing Solutions to Advance Your COVID-19 Clinical Trials

Developing a vaccine or therapeutic in response to the outbreak of the 2019 Novel Coronavirus (COVID-19) requires a laboratory with significant technical and cross-functional experience. Our Central Laboratories are prepared to support your COVID-19 studies.

Featured Video

Propel Your Biomarker Strategy

PhD-level leaders within our Biomarker Solution Center can provide specialized therapeutic area expertise to create a successful biomarker strategy for your next study.

Clinical Testing Services for Drug Development

Biomarker-driven trial design and testing add complexity to the drug development process, with laboratory support required at every phase. 

We are committed to helping you navigate the process, providing comprehensive scientific and medical support to complement your drug development program.

Clinical testing in a lab

Educational Insights

Trends in Immuno-Oncology from Preclinical Models Through Biomarkers and Clinical Trial Design

Trends in Immuno-Oncology from Preclinical Models Through Biomarkers and Clinical Trial Design

Videos & Webinars
Learn from three thought leaders in the field of immunotherapy as they share their knowledge on trends and advances across the entire spectrum of development.
Read More

Let us know about your interests and one of our specialists will contact you directly.


Contact Us